Friday, 23 October 2015

FDA Warns AbbVie’s Hepatitis C Drugs Could Harm Liver

Some patients with advanced forms of the disease experienced liver failure, the FDA says, after taking Viekira Pak and Technivie. Gilead, which makes a rival hepatitis C drug, may benefit, analysts say.

No comments:

Post a Comment